Roche Holding AG (ROG) — Stock analysis
USDCurrent price
52,55 USD
0,17 USD (+0.32%) today
Market signals
About Roche Holding AG
Roche is one of the world's largest pharmaceutical and diagnostics groups, headquartered in Basel, Switzerland. It operates in two main divisions: Pharmaceuticals (innovative drugs in oncology, neuroscience, immunology, infectious diseases — including Herceptin, Avastin, Rituxan, Ocrevus, Tecentriq) and Diagnostics (in-vitro diagnostics instruments and tests, including Cobas). Fully owns Genentech (US). Two share classes exist: ROG (non-voting bearer shares) and ROG registered shares.
What does Roche do?▾
Roche develops drugs for oncology (Herceptin, Avastin, Rituxan, Tecentriq, Perjeta), neurology (Ocrevus for multiple sclerosis), immunology and infectious diseases. The Diagnostics division makes laboratory tests and in-vitro diagnostic systems (Cobas, Elecsys). It fully owns Genentech USA.
Which exchange is Roche listed on?▾
Roche is listed on the SIX Swiss Exchange with ticker ROG (non-voting bearer shares). It is a member of the SMI (Swiss Market Index). ADRs are available in the US OTC market as RHHBY.
Does Roche pay dividends?▾
Yes. It pays a progressively growing annual dividend for over 35 consecutive years. Yield is typically 3–4%.
Analyse this stock with AI
Create a free account and get 2 credits to generate a complete analysis.
Create account · 2 free credits